Published in PLoS Biol on May 24, 2011
Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling. Cell (2015) 2.38
The Mycobacterium tuberculosis regulatory network and hypoxia. Nature (2013) 2.04
Antibiotic efficacy is linked to bacterial cellular respiration. Proc Natl Acad Sci U S A (2015) 1.76
Fresh approaches to anti-infective therapies. Sci Transl Med (2012) 1.67
Microbial persistence and the road to drug resistance. Cell Host Microbe (2013) 1.37
Bactericidal Antibiotics Induce Toxic Metabolic Perturbations that Lead to Cellular Damage. Cell Rep (2015) 1.31
Activity of 3-ketosteroid 9α-hydroxylase (KshAB) indicates cholesterol side chain and ring degradation occur simultaneously in Mycobacterium tuberculosis. J Biol Chem (2011) 1.06
The normalcy of dormancy: common themes in microbial quiescence. Cell Host Microbe (2013) 1.03
Iron and citrate export by a major facilitator superfamily pump regulates metabolism and stress resistance in Salmonella Typhimurium. Proc Natl Acad Sci U S A (2013) 0.99
Acylation of Biomolecules in Prokaryotes: a Widespread Strategy for the Control of Biological Function and Metabolic Stress. Microbiol Mol Biol Rev (2015) 0.99
Slow growth of Mycobacterium tuberculosis at acidic pH is regulated by phoPR and host-associated carbon sources. Mol Microbiol (2014) 0.94
Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria. Microbiol Spectr (2014) 0.93
Metabolic aspects of bacterial persisters. Front Cell Infect Microbiol (2014) 0.91
Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review. Semin Immunopathol (2015) 0.90
Lipidomic analysis links mycobactin synthase K to iron uptake and virulence in M. tuberculosis. PLoS Pathog (2015) 0.88
Comparative Ser/Thr/Tyr phosphoproteomics between two mycobacterial species: the fast growing Mycobacterium smegmatis and the slow growing Mycobacterium bovis BCG. Front Microbiol (2015) 0.88
Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo. J Exp Med (2016) 0.88
Biotin biosynthesis in Mycobacterium tuberculosis: physiology, biochemistry and molecular intervention. Protein Cell (2011) 0.88
Targeting drug tolerance in mycobacteria: a perspective from mycobacterial biofilms. Expert Rev Anti Infect Ther (2012) 0.87
Metabolic crosstalk between host and pathogen: sensing, adapting and competing. Nat Rev Microbiol (2016) 0.87
Trace incorporation of heavy water reveals slow and heterogeneous pathogen growth rates in cystic fibrosis sputum. Proc Natl Acad Sci U S A (2015) 0.85
Wax ester synthesis is required for Mycobacterium tuberculosis to enter in vitro dormancy. PLoS One (2012) 0.85
Antimicrobial treatment improves mycobacterial survival in nonpermissive growth conditions. Antimicrob Agents Chemother (2014) 0.84
Deficiency of the novel exopolyphosphatase Rv1026/PPX2 leads to metabolic downshift and altered cell wall permeability in Mycobacterium tuberculosis. MBio (2015) 0.84
Extensive in vivo resilience of persistent Salmonella. PLoS One (2012) 0.83
New insights into TB physiology suggest untapped therapeutic opportunities. Immunol Rev (2015) 0.83
Succinate dehydrogenase is the regulator of respiration in Mycobacterium tuberculosis. PLoS Pathog (2014) 0.83
Ergothioneine Maintains Redox and Bioenergetic Homeostasis Essential for Drug Susceptibility and Virulence of Mycobacterium tuberculosis. Cell Rep (2016) 0.82
Essentiality of succinate dehydrogenase in Mycobacterium smegmatis and its role in the generation of the membrane potential under hypoxia. MBio (2014) 0.81
Insights into redox sensing metalloproteins in Mycobacterium tuberculosis. J Inorg Biochem (2013) 0.80
Equation-free analysis of two-component system signalling model reveals the emergence of co-existing phenotypes in the absence of multistationarity. PLoS Comput Biol (2012) 0.80
Experimental Models of Foamy Macrophages and Approaches for Dissecting the Mechanisms of Lipid Accumulation and Consumption during Dormancy and Reactivation of Tuberculosis. Front Cell Infect Microbiol (2016) 0.79
High Persister Mutants in Mycobacterium tuberculosis. PLoS One (2016) 0.78
Clonal Diversification and Changes in Lipid Traits and Colony Morphology in Mycobacterium abscessus Clinical Isolates. J Clin Microbiol (2015) 0.77
Mycobacterium tuberculosis Transcription Machinery: Ready To Respond to Host Attacks. J Bacteriol (2016) 0.77
Interactions among filamentous fungi Aspergillus niger, Fusarium verticillioides and Clonostachys rosea: fungal biomass, diversity of secreted metabolites and fumonisin production. BMC Microbiol (2016) 0.77
Oleoyl coenzyme A regulates interaction of transcriptional regulator RaaS (Rv1219c) with DNA in mycobacteria. J Biol Chem (2014) 0.76
Mycobacterium tuberculosis metabolism. Cold Spring Harb Perspect Med (2014) 0.76
Outcome correlation of smear-positivity but culture-negativity during standard anti-tuberculosis treatment in Taiwan. BMC Infect Dis (2015) 0.76
Sublethal Concentrations of Antibiotics Cause Shift to Anaerobic Metabolism in Listeria monocytogenes and Induce Phenotypes Linked to Antibiotic Tolerance. Front Microbiol (2016) 0.76
Playing TAG with a bacterial stress response. PLoS Biol (2011) 0.75
Metabolic modeling predicts metabolite changes in Mycobacterium tuberculosis. BMC Syst Biol (2015) 0.75
Next-generation antimicrobials: from chemical biology to first-in-class drugs. Arch Pharm Res (2015) 0.75
Metabolic Perspectives on Persistence. Microbiol Spectr (2017) 0.75
The stringent response factors PPX1 and PPK2 play an important role in Mycobacterium tuberculosis metabolism, biofilm formation, and sensitivity to isoniazid in vivo. Antimicrob Agents Chemother (2016) 0.75
The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition. Microbes Infect (2016) 0.75
In-Vivo Gene Signatures of Mycobacterium tuberculosis in C3HeB/FeJ Mice. PLoS One (2015) 0.75
Targeting Phenotypically Tolerant Mycobacterium tuberculosis. Microbiol Spectr (2017) 0.75
Multiscale Model of Mycobacterium tuberculosis Infection Maps Metabolite and Gene Perturbations to Granuloma Sterilization Predictions. Infect Immun (2016) 0.75
The Minimal Unit of Infection: Mycobacterium tuberculosis in the Macrophage. Microbiol Spectr (2016) 0.75
Targeting Mycobacterium tuberculosis Tumor Necrosis Factor Alpha-Downregulating Genes for the Development of Antituberculous Vaccines. MBio (2016) 0.75
Mycobacterium tuberculosis proteome response to anti-tuberculosis compounds reveals metabolic "escape" pathways that prolong bacterial survival. Antimicrob Agents Chemother (2017) 0.75
Rv3723/LucA coordinates fatty acid and cholesterol uptake in Mycobacterium tuberculosis. Elife (2017) 0.75
Anaerobic Mycobacterium tuberculosis cell death stems from intracellular acidification mitigated by the DosR regulon. J Bacteriol (2017) 0.75
A common mechanism of cellular death induced by bactericidal antibiotics. Cell (2007) 12.92
An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun (1996) 9.21
Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A (2003) 9.15
Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature (1970) 9.07
Comprehensive identification of conditionally essential genes in mycobacteria. Proc Natl Acad Sci U S A (2001) 6.22
Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol (2003) 5.68
Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun (2008) 4.93
Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci U S A (2008) 4.92
The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc Natl Acad Sci U S A (2000) 4.82
PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release. Science (2008) 4.74
M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) (2004) 4.38
The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci U S A (1998) 3.47
Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med (2008) 3.01
The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2008) 2.92
Replication dynamics of Mycobacterium tuberculosis in chronically infected mice. Infect Immun (2005) 2.74
Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture. J Bacteriol (2004) 2.51
A replication clock for Mycobacterium tuberculosis. Nat Med (2009) 2.49
Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev (2007) 2.42
A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS One (2009) 2.15
Effects of antibiotics and a proto-oncogene homolog on destruction of protein translocator SecY. Science (2009) 1.96
Mechanism of lipid-body formation in prokaryotes: how bacteria fatten up. Mol Microbiol (2005) 1.83
The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J Bacteriol (2009) 1.75
Complex pattern of Mycobacterium marinum gene expression during long-term granulomatous infection. Proc Natl Acad Sci U S A (2002) 1.70
Identification of a diacylglycerol acyltransferase gene involved in accumulation of triacylglycerol in Mycobacterium tuberculosis under stress. Microbiology (2006) 1.66
Carbon flux rerouting during Mycobacterium tuberculosis growth arrest. Mol Microbiol (2010) 1.43
Predictive in vitro models of the sterilizing activity of anti-tuberculosis drugs. Curr Pharm Des (2004) 1.39
DosS responds to a reduced electron transport system to induce the Mycobacterium tuberculosis DosR regulon. J Bacteriol (2010) 1.30
Prospects for advancing tuberculosis control efforts through novel therapies. PLoS Med (2006) 1.27
Phthiocerol dimycocerosate transport is required for resisting interferon-gamma-independent immunity. J Infect Dis (2009) 1.26
Levels of glycogen and trehalose in Mycobacterium smegmatis and the purification and properties of the glycogen synthetase. J Bacteriol (1973) 1.20
Lipid composition and transcriptional response of Mycobacterium tuberculosis grown under iron-limitation in continuous culture: identification of a novel wax ester. Microbiology (2007) 1.13
A new single-copy mycobacterial plasmid, pMF1, from Mycobacterium fortuitum which is compatible with the pAL5000 replicon. Microbiology (2000) 1.10
Signals of growth regulation in bacteria. Curr Opin Microbiol (2009) 1.06
Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci U S A (2008) 4.92
High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog (2011) 4.10
Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β. Nat Immunol (2012) 2.34
NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog (2009) 2.31
Characterization of mycobacterial virulence genes through genetic interaction mapping. Proc Natl Acad Sci U S A (2006) 2.29
Global assessment of genomic regions required for growth in Mycobacterium tuberculosis. PLoS Pathog (2012) 1.85
igr Genes and Mycobacterium tuberculosis cholesterol metabolism. J Bacteriol (2009) 1.82
Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations. Chem Biol (2012) 1.79
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide. J Exp Med (2009) 1.68
Depletion of antibiotic targets has widely varying effects on growth. Proc Natl Acad Sci U S A (2011) 1.54
The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria. Mol Microbiol (2004) 1.43
A phosphorylated pseudokinase complex controls cell wall synthesis in mycobacteria. Sci Signal (2012) 1.41
Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis. PLoS One (2013) 1.31
Phthiocerol dimycocerosate transport is required for resisting interferon-gamma-independent immunity. J Infect Dis (2009) 1.26
Nitrile-inducible gene expression in mycobacteria. Tuberculosis (Edinb) (2008) 1.18
Role of cholesterol in Mycobacterium tuberculosis infection. Indian J Exp Biol (2009) 1.11
Transposon site hybridization in Mycobacterium tuberculosis. Methods Mol Biol (2008) 1.06
DNA methylation impacts gene expression and ensures hypoxic survival of Mycobacterium tuberculosis. PLoS Pathog (2013) 1.03
The normalcy of dormancy: common themes in microbial quiescence. Cell Host Microbe (2013) 1.03
Cyclic AMP regulation of protein lysine acetylation in Mycobacterium tuberculosis. Nat Struct Mol Biol (2012) 1.02
Bayesian analysis of gene essentiality based on sequencing of transposon insertion libraries. Bioinformatics (2013) 1.01
Role in metal homeostasis of CtpD, a Co²⁺ transporting P(1B4)-ATPase of Mycobacterium smegmatis. Mol Microbiol (2012) 0.95
A novel P(1B)-type Mn2+-transporting ATPase is required for secreted protein metallation in mycobacteria. J Biol Chem (2013) 0.92
Biochemical and spatial coincidence in the provisional Ser/Thr protein kinase interaction network of Mycobacterium tuberculosis. J Biol Chem (2014) 0.92
Differential roles for the Co(2+) /Ni(2+) transporting ATPases, CtpD and CtpJ, in Mycobacterium tuberculosis virulence. Mol Microbiol (2013) 0.91
Endoglycan, a member of the CD34 family, functions as an L-selectin ligand through modification with tyrosine sulfation and sialyl Lewis x. J Biol Chem (2003) 0.89
A new site-specific integration system for mycobacteria. Tuberculosis (Edinb) (2005) 0.86
New insights into TB physiology suggest untapped therapeutic opportunities. Immunol Rev (2015) 0.83
Identifying essential genes in Mycobacterium tuberculosis by global phenotypic profiling. Methods Mol Biol (2015) 0.83
Mycobacterial recombineering. Methods Mol Biol (2015) 0.83
Two-dimensional bacterial genome display: a method for the genomic analysis of mycobacteria. Microbiology (2002) 0.80
Relics of selection in the mycobacterial genome. Nat Genet (2010) 0.79
The open book of infectious diseases. Nat Med (2007) 0.78
Infection control in cystic fibrosis: share and share alike. Lancet (2013) 0.77
Genetic Strategies for Identifying New Drug Targets. Microbiol Spectr (2014) 0.76